Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz INIBICA: Envíos recientes
Mostrando ítems 21-40 de 1173
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
(Oxford University Press, 2023-09) -
Consenso sobre el algoritmo diagnóstico del prurigo crónico nodular
(Elsevier Espana S.L.U, 2024-11) -
Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis From the Patient’s Perspective: A Systematic Review
(American Contact Dermatitis Society, 2023) -
Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up
(American Contact Dermatitis Society, 2024-02) -
Associations of psychosocial factors with cardiovascular health in aging: insights from the Inlife-Aging Project
(Springer Nature, 2026-05-02) -
El desarrollo de la Expresión Corporal en España: Mercè Mateu, una maestra inspiradora
(Generalitat de Catalunya Departament de la Presidència Institut Nacional d’Educació Física de Catalunya, 2026) -
Health literacy training for older adults: A systematic review with meta-analysis
(Springer Nature, 2026-04) -
Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome
(Clinical and Experimental Rheumatology, 2013) -
Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome
(Clinical and Experimental Rheumatology - 2012, vol. 30, nº 5, pp. 686-692, 2012) -
Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence
(Springer, 2011-04) -
Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance
(Clinical and Experimental Rheumatology, 2010)
